|
|
 |
|
Viewing report
|
|
|
|
Drug Delivery for Self-Administration Report - Technologies, Combination
Greystone Associates, Dec 2007, Pages: 295
As the trend toward drug combination products for prescription drugs grows, a number of factors are converging to create both risk and opportunity for drug makers and their device partners. These include new classes of drugs for previously refractory conditions, the growing trend toward self-administration for chronic diseases, shifting patient demographics in industrial countries, and continued pressure to control healthcare costs. The recent escalation in new biological drugs indicated for chronic ailments is placing renewed emphasis on simple and reliable devices for the self administration of prescription drugs. These factors are giving rise to a new generation of sophisticated, application-specific drug delivery devices designed to satisfy caregiver and patient preferences while addressing managed care initiatives and the limitations of new classes of therapeutic drugs. User-friendly designs and the availability of an increasing number of drug combination products are propelling acceptance of user friendly combination products at the expense of other drug delivery methods. Because of their ability to safely and reliably satisfy treatment protocols and compliance goals, drug combination products will have a significant impact on the future of drug self administration.
Advancing Technology and Tailored Delivery Devices:
While alternative methods for delivering therapeutics to patients have had some notable successes, most drugs continue to be delivered either orally or by injection. Because they cannot tolerate the first-pass metabolism of the digestive tract, the recent escalation in new biological drugs, including antibodies and recombinant proteins, is placing renewed emphasis on drug injection. Now a number of factors are converging to create both risk and opportunity for parenteral drug makers and their device partners. These include new classes of drugs for previously refractory conditions, the growing trend toward self-administration for chronic diseases, shifting patient demographics in industrial countries, caregiver safety legislation, and continued pressure to control healthcare costs.
These factors are giving rise to a new generation of sophisticated, application-specific injection devices designed to satisfy caregiver and patient preferences while addressing managed care initiatives and the limitations of new classes of therapeutic drugs. User-friendly designs and the availability of an increasing number of drugs in pre-filled disposable cartridges and syringes are propelling the growth of injector pens at the expense of other drug delivery methods such as traditional syringes. Because of their ability to safely and reliably satisfy treatment protocols and compliance goals, these new devices will have a significant impact on the future of drug self administration.
Market Data
The study presents qualitative and quantitative data and information on key market measures and benchmarks:
- Market Segment Data
- Economic Factors
- Company Profiles
- Injector Design Criteria
- Product Status & Prospects
- Market Projections
- Industry Structure
- Strategic Alliances
- Emerging Markets
- Market Penetration Factors
- Technology Factors
- Regulatory Factors
Customers who bought this item also bought
Injectable Drug Delivery
Drug Delivery: Active Transdermal Delivery Systems
Transdermal Drug Delivery - Technologies, Markets, and Companies
Prefilled Syringes - Drugs, Devices and Disease Therapeutics
Transdermal Drug Delivery: Patches, Gels, Active Systems, Therapeutics, Markets & Forecasts
Active Transdermal Delivery
The Top 40 Transdermal Drug Delivery Technology Companies Worldwide
Drug Delivery in Cancer - Technologies, Markets and Companies
Nanoparticle Drug Delivery Market Report
Drug Delivery Technology - Revolutionizing CNS Therapies
Transdermal Pain Management: Markets, Demand Factors, Forecasts, and Opportunities
Cardiovascular Drug Delivery - Technologies, Markets and Companies
|
|
|
|
